About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 331 record(s)
Req # A-2021-001238
The month and year that the Abbreviated New Drug Submission (ANDS) for degarelix acetate was accepted into review; and the status of the ANDS review for degarelix acetate.Organization: Health Canada
March 2022
Req # A-2021-001241
According to the Health Canada Generic Submissions Under Review List, an Abbreviated New Drug Submission (ANDS) for degarelix acetate was submitted on or after October 1, 2018. Advise the dosage form in which it is proposed that the new drug be sold, as described in paragraph C.08.002(2)(l) of the Food and Drug Regulations.Organization: Health Canada
March 2022
Req # A-2021-001251
Any contracts, receipts, invoices, bills, etc. relating to vaccine manufacturers (such as Pfizer or Moderna) in communication with the Ministry of Health from 1 March 2020 through 25 October 2021.Organization: Health Canada
March 2022
March 2022
Req # A-2021-001392
All Health Briefing materials given to Health Minister Jean-Yves Duclos after the 2021 federal election.Organization: Health Canada
March 2022
Req # A-2021-001461
The briefing book that was given to the Honourable Jean-Yves Duclos after being appointed Health Minister in the fall of 2021.Organization: Health Canada
March 2022
Req # A-2021-001572
Apotex lnc. Form Vs for Apo-perindopril arginine/amlodipine besylate, oral tablet, 3.5 mg/2.5 mg (Drug Identification Number (DIN) # 02468565), 7mg/5mg (DIN # 02468573) and 14mg/10mg (DIN # 02468581).Organization: Health Canada
March 2022
Req # A-2021-001687
Based on it's own modelling, how many people in Canada are predicted to die as a direct consequence of climate change by 2030, and by 2050? All data from all sources covering 2015 to December 31, 2021.Organization: Health Canada
March 2022
Req # A-2021-001741
The Screening Acceptance Letter(s) from Health Canada to any and all generic drug manufacturers confirming receipt of any and all Abbreviated New Drug Submissions for levothyroxine sodium which appear on the list of Generic submissions under review.Organization: Health Canada
March 2022
Req # A-2021-001746
Any report held by Health Canada regarding Quebec cannabis producer HEXO referring to its links with an individual associated with the Hells Angels or members of organized crime, between January 9, 2021 and January 9, 2022.Organization: Health Canada
March 2022